Kenneth Carl Anderson insider trades

Open-market stock purchases and sales by Kenneth Carl Anderson, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2020.

Recent trades

DateStockTradeValue
Jun 24, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Jun 1, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Apr 1, 2026CCCC C4 Therapeutics, IncBought (not open market)$11.5K
Jan 2, 2026CCCC C4 Therapeutics, IncBought (not open market)$11.5K

Companies traded

  • CCCC C4 Therapeutics, Inc: other filings, last Jun 24, 2026

Get free alerts when Kenneth Carl Anderson files a new trade →